EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG

Rameen Shah iD, Rohit Budhraja, Silvia Radenkovic iD, Graeme Preston iD, Alexia Tyler King, Sahar Sabry, Charlotte Bleukx, Ibrahim Shammas iD, Lyndsay Young, Jisha Chandran, Seul Kee Byeon, Ronald Hrstka und 7 weitere

Cells · 2026

DOI: 10.3390/cells15020147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Rameen Shah und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Glucosyltransferases, Cadherins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ALG13-CDG is an X-linked N-linked glycosylation disorder caused by pathogenic variants in the glycosyltransferase ALG13, leading to severe neurological manifestations. Despite the clear CNS involvement, the impact of ALG13 dysfunction on human brain glycosylation and neurodevelopment remains unknown. We hypothesize that ALG13-CDG causes brain-specific hypoglycosylation that disrupts neurodevelopmental pathways and contributes directly to cortical network dysfunction.

Methods

We generated iPSC-derived human cortical organoids (hCOs) from individuals with ALG13-CDG to define the impact of hypoglycosylation on cortical development and function. Electrophysiological activity was assessed using MEA recordings and integrated with multiomic profiling, including scRNA-seq, proteomics, glycoproteomics, N-glycan imaging, lipidomics, and metabolomics. X-inactivation status was evaluated in both iPSCs and hCOs.

Results

ALG13-CDG hCOs showed reduced glycosylation of proteins involved in ECM organization, neuronal migration, lipid metabolism, calcium homeostasis, and neuronal excitability. These pathway disruptions were supported by proteomic and scRNA-seq data and included altered intercellular communication. Trajectory analyses revealed mistimed neuronal maturation with early inhibitory and delayed excitatory development, indicating an E/I imbalance. MEA recordings demonstrated early network hypoactivity with reduced firing rates, immature burst structure, and shortened axonal projections, while transcriptomic and proteomic signatures suggested emerging hyperexcitability. Altered lipid and GlcNAc metabolism, along with skewed X-inactivation, were also observed.

Conclusions

Our study reveals that ALG13-CDG is a disorder of brain-specific hypoglycosylation that disrupts key neurodevelopmental pathways and destabilizes cortical network function. Through integrated multiomic and functional analyses, we identify early network hypoactivity, mistimed neuronal maturation, and evolving E/I imbalance that progresses to compensatory hyperexcitability, providing a mechanistic basis for seizure vulnerability. These findings redefine ALG13-CDG as disorders of cortical network instability, offering a new framework for targeted therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital Disorders of GlycosylationGlucosyltransferasesCadherinsHumansNeurodevelopmentGlycosylationInduced Pluripotent Stem CellsMultiomicsNeurons

Stichwörter der Autor:innen

ALG13 deficiencyN-linked glycosylationX-chromosome inactivation skewingcongenital disorders of glycosylation (CDG)cortical brain organoidsexcitatory–inhibitory imbalanceinfantile spasms and epilepsymulti-omics analysisnetwork hypoactivity

Substanzen

GlucosyltransferasesCadherins

Autor:innen und Institutionen

  • Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY 10028, USA.
  • Renaissiance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Genetics, Section Metabolic Diagnostics, University Medical Center Utrecht, 3584 EA Utrecht, The Netherlands.

ORCID-Profile: Rameen Shah, Silvia Radenkovic, Graeme Preston, Ibrahim Shammas, Akhilesh Pandey, Eva Morava, Tamas Kozicz

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS
  • Wellcome Trust
  • DBT/Wellcome Trust India Alliance
  • the National Institute of Neurological Diseases and Stroke (NINDS), the National Center for Advancing Translational Sciences (NCATS), the National Institute of…

Zitieren

APA

Shah, R., Budhraja, R., Radenkovic, S., Preston, G., King, A. T., Sabry, S., Bleukx, C., Shammas, I., Young, L., Chandran, J., Byeon, S. K., Hrstka, R., Smith, D. Y., Staff, N. P., Drake, R., Sloan, S. A., Pandey, A., Morava, E., & Kozicz, T. (2026). Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG. Cells. https://doi.org/10.3390/cells15020147

Vancouver

Shah R, Budhraja R, Radenkovic S, Preston G, King AT, Sabry S, et al. Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG. Cells. 2026. doi:10.3390/cells15020147

BibTeX
@article{Shah2026,
  author = {Shah, Rameen and Budhraja, Rohit and Radenkovic, Silvia and Preston, Graeme and King, Alexia Tyler and Sabry, Sahar and Bleukx, Charlotte and Shammas, Ibrahim and Young, Lyndsay and Chandran, Jisha and Byeon, Seul Kee and Hrstka, Ronald and Smith, Doughlas Y and Staff, Nathan P and Drake, Richard and Sloan, Steven A and Pandey, Akhilesh and Morava, Eva and Kozicz, Tamas},
  title = {Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDG},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15020147}
}
Kostenlos starten →